668 related articles for article (PubMed ID: 30702818)
21. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
He YW; Guo CX; Pan YF; Peng C; Weng ZH
World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
24. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
25. Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen.
Li B; Wang Y; Shen F; Wu M; Li Y; Fang Z; Ye J; Wang L; Gao L; Yuan Z; Chen J
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224536
[TBL] [Abstract][Full Text] [Related]
26. [The inhibitory effect of Chinese herb Phyllanthus on hepatitis B virus in vitro].
Liu Z; Fu X; Zhang N; Zhang G; Liu D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):282-5. PubMed ID: 15617349
[TBL] [Abstract][Full Text] [Related]
27. Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.
Yang HY; Zheng NQ; Li DM; Gu L; Peng XM
Virol J; 2014 Sep; 11():165. PubMed ID: 25224377
[TBL] [Abstract][Full Text] [Related]
28. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
J Virol; 2020 May; 94(11):. PubMed ID: 32188736
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
32. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
33. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
[TBL] [Abstract][Full Text] [Related]
34. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
35. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
Rang A; Günther S; Will H
J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
[TBL] [Abstract][Full Text] [Related]
36. NIRF, a Novel Ubiquitin Ligase, Inhibits Hepatitis B Virus Replication Through Effect on HBV Core Protein and H3 Histones.
Qian G; Hu B; Zhou D; Xuan Y; Bai L; Duan C
DNA Cell Biol; 2015 May; 34(5):327-32. PubMed ID: 25664994
[TBL] [Abstract][Full Text] [Related]
37. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication.
Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X
Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
39. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
Tian H; He Z
Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
[TBL] [Abstract][Full Text] [Related]
40. Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.
Xu WZ; Fang Y; Li D; Wang Y; Shang QL; Li GQ; Teng X; Gu HX
World J Gastroenterol; 2008 Jun; 14(23):3733-8. PubMed ID: 18595141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]